Febit Acquires License From OGT
News Nov 21, 2005
febit biotech gmbh has announced that it has acquired a license from Oxford Gene Technology (OGT) from Oxford, UK.
The acquired license refers to patents on technologies that were developed in the 80ies by OGT’s founder, Professor Edwin M. Southern.
The "Southern array patents" are the fundamental patents covering the manufacture and use of DNA microarrays in genetic and genomic research.
"We are delighted about the successful conclusion of the agreement with OGT, which further strengthens our IP position to successfully market our GENIOM® technology worldwide," says Cord F. Stahler, President & CEO of febit biotech gmbh.
Dr. Mike Evans, Chief Executive of OGT adds, "We are happy to support febit biotech’s technology by granting this license and thus further the use of microarray technology."
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE